Portable diagnostics that reach communities where geography, workforce shortages, and infrastructure create barriers to health screening access. Designed for Indigenous health, remote clinics, and public health programs.
Remote and regional communities face structural barriers: limited workforce, vast distances, and fragmented diagnostic pathways that delay detection and intervention for chronic disease.
5.6kg. Standalone power. Satellite connectivity. Operates in settings with no mains power, no internet infrastructure, and no laboratory access.
Operable by community health workers without specialist medical qualifications. Training completed in 1-2 days.
Results available instantly for remote clinical review. A GP or specialist can consult on live results from anywhere in Australia or the Pacific.
Five drops of capillary blood. No needles, no phlebotomist. Reduces screening barriers in communities with needle anxiety or limited clinical workforce.
De-identified, aggregated analytics support PHN reporting, Closing the Gap metrics, and evidence-based resource allocation for health programs.
Patient-controlled data through the Health Passport. Consent-based sharing. Designed in consultation with Indigenous health leaders.
EVEDA aligns with national priorities for Aboriginal and Torres Strait Islander health outcomes by enabling comprehensive chronic disease screening in community-controlled health settings.
The platform supports the shift from reactive treatment to proactive prevention, identifying risk factors for diabetes, cardiovascular disease, kidney disease, and respiratory conditions before they escalate.
EVEDA is committed to fostering reconciliation and building respectful relationships with Indigenous peoples. Our advisory board includes leading Indigenous health experts who guide the ethical and culturally safe deployment of our technology.